OnCore Login

Return to Trial Database

HCRN-BRE94-1

A Hoosier Oncology Group Phase II Study of Biweekly Cisplatin (C) and Paclitaxel (P) in the Treatment of Metastatic Breast Cancer: A Hoosier Oncology Group (HOG) and Walther Cancer Institute Trial BRE94-1

Status

Study Completed

Cancer Type(s)

Breast

Study Contact

Publications

A Phase II Study of Biweekly Cisplatin (C) and Paclitaxel (P) in the Treatment of Metastatic Breast Cancer
  • W McCaskill-Stevens, R Ansari, W Fisher, K Pennington, C Dobbs, R Gonin, S Schafer, D Loesch, G Sledge

Trial Locations

All sites in which the trial HCRN-BRE94-1 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278